سهم تغيير تاريخ
AstraZeneca USD 6.57B 13M 2026-03
Genmab DKK 13M 1000K 2025-06
GlaxoSmithKline GBP 6.16B 233M 2026-03
GRIFOLS EUR 3.35B 213.23M 2025-06
Hikma Pharmaceutical USD 1.08B 96M 2025-06
Lakefront Biotherapeutics EUR 17.69M 4.8M 2026-03
Qiagen NV USD 301.89M 11.66M 2025-12
UCB EUR 1.31B 173M 2024-12